JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. - Pennel, Kathryn A. F.; Hatthakarnkul, Phimmada; Wood, Colin S.; Lian, Guang-Yu; Al-Badran, Sara S. F.; Quinn, Jean A.; Legrini, Assya; Inthagard, Jitwadee; Alexander, Peter G.; van Wyk, Hester; Kurniawan, Ahmad; Hashmi, Umar; et al. (Journal of Experimental & Clinical Cancer Research (17569966), 2024)